Thermo Fisher discloses $550,000 in quarterly lobbying spend
Alpha Vantage · Quiver Quantitative · · AI-summarised by FinFlash
Thermo Fisher Scientific disclosed $550,000 in lobbying expenditures for Q3 2026, covering tax priorities, regulatory matters, clinical trials infrastructure, diagnostic reimbursement policies and several legislative bills. The filing also details congressional and insider trading activity in TMO shares, hedge fund movements and analyst price targets.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.